models
process
1
iPSC Line Generation - We generate induced pluripotent stem cell (iPSC) lines through two complementary approaches:
- Patient-derived lines: Reprogram cells from patient samples carrying disease-relevant mutations
- Engineered lines: Introduce precise mutations into our in-house control iPSC lines using CRISPR-Cas9 gene editing technology.
2
Scalable Neuronal Differentiation - Using our proprietary differentiation protocols, we convert iPSC lines into distinct neuronal subtypes at scale, generating cryopreserved stocks of billions of functional neurons.
3
Quality Assurance - Each neuronal stock undergoes comprehensive quality control testing prior to cryopreservation, ensuring batch-to-batch reproducibility and consistent performance across experiments.